WOMEN in Scotland who are diagnosed with advanced ovarian cancer or who suffer a relapse of the disease will be unable to access a drug available to patients in England.
The Scottish Medicines Consortium (SMC) said it was not cost effective to recommend bevacizumab – brand name Avastin – on the NHS to treat women with recurrent ovarian cancer.
The move follows a previous ruling against recommending the drug for use in patients with advanced ovarian cancer.
Avastin is used in Europe and available to women in England through its unique Cancer Drugs Fund, but has also been rejected by drug authorities in Wales and Northern Ireland.
Patients in Scotland are only able to access drugs rejected by the SMC if their doctors pursues an individual patient treatment request on their behalf.
Professor Charlie Gourley, Professor and Honorary Consultant in Medical Oncology at the University of Edinburgh, said: "It is extremely disappointing that oncologists in Scotland who treat women with recurrent ovarian cancer do not have access to Avastin.
"The negative SMC decision and the lack of a Cancer Drugs Fund in Scotland will prevent patients benefitting from an extra four months without the signs and symptoms of their disease."
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article